Guardant Health (NASDAQ:GH) Given New $60.00 Price Target at Canaccord Genuity Group
Guardant Health (NASDAQ:GH – Get Free Report) had its target price increased by equities research analysts at Canaccord Genuity Group from $42.00 to $60.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would suggest a potential upside of 48.70% […]
Guardant Health (NASDAQ:GH – Get Free Report) had its target price increased by equities research analysts at Canaccord Genuity Group from $42.00 to $60.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would suggest a potential upside of 48.70% […]
